Bad breath (medically known as halitosis) is a symptom of gastrointestinal (GI) conditions, such as acid reflux and ulcers.

New research led by the University of Portsmouth has revealed how Duchenne muscular dystrophy (DMD), best known for causing ...

Sarepta Therapeutics announced that a patient with Duchenne muscular dystrophy who received Elevidys (delandistrogene moxeparvovec-rokl) died following treatment.

New research led by the University of Portsmouth has revealed how Duchenne muscular dystrophy (DMD), best known for causing ...

A UK-wide awards ceremony has seen a Newton Abbot mum win an outstanding achievement award for raising funds and awareness of ...

A Reed City family is partnering with the Jett Foundation to help raise money for a wheelchair-accessible van.14-year-old ...

WVE-N531 demonstrated statistically significant improvements in muscle biopsy measures and functional measures in patients ...

Wave Life Sciences Ltd. shares promising updates on AATD & DMD treatments. Click here for my updated look at WVE stock ...

The first disease modifying therapies for Alzheimer’s may have limited utility in some senses, but they will be a force for ...

The patient died of acute liver failure; the maker of the gene therapy noted that the patient also had a recent ...

Wave Life Sciences’ Phase II open-label trial investigating its disease-modifying drug for boys living with Duchenne Muscular ...

Several companies will head to the FDA seeking approval of new Duchenne muscular dystrophy treatments next year but the death of a patient taking Sarepta’s Elevidys raises important safety questions.